LIPOPROTEIN(A) AND ATHEROGENESIS

被引:45
作者
LIU, AC
LAWN, RM
机构
关键词
D O I
10.1016/1050-1738(94)90024-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lipoprotein(a) is a major inherited risk factor for atherosclerosis. Many of ifs activities depend on ifs plasminlike component, apolipoprotein(a). In vitro studies suggest that apolipoprotein(a) could enhance lipid deposition through binding to sites in the vessel wall, interfere with fibrinolysis, and modulate smooth muscle cell activity. Human and animal studies will be necessary to establish the physiologic importance of these mechanisms.
引用
收藏
页码:40 / 44
页数:5
相关论文
共 53 条
[1]   THE INCREASED PLASMA LP(A) - B-LIPOPROTEIN PARTICLE CONCENTRATION IN ANGINA-PECTORIS IS NOT ASSOCIATED WITH HYPOFIBRINOLYSIS [J].
ALESSI, MC ;
PARRA, HJ ;
JOLY, P ;
VUDAC, N ;
BARD, JM ;
FRUCHART, JC ;
JUHANVAGUE, I .
CLINICA CHIMICA ACTA, 1990, 188 (02) :119-127
[2]  
ARMSTRONG VW, 1985, J LIPID RES, V26, P1314
[3]  
BOTTALICO LA, 1993, J BIOL CHEM, V268, P8569
[4]  
BREWER HB, 1990, LIPOPROTEIN, P271
[5]   PLASMA-LIPOPROTEINS - TEACHING OLD DOGMAS NEW TRICKS [J].
BROWN, MS ;
GOLDSTEIN, JL .
NATURE, 1987, 330 (6144) :113-114
[6]  
CHIESA G, 1992, J BIOL CHEM, V267, P24369
[7]   QUANTITATION AND LOCALIZATION OF APOLIPOPROTEIN[A] AND APOLIPOPROTEIN-B IN CORONARY-ARTERY BYPASS VEIN GRAFTS RESECTED AT REOPERATION [J].
CUSHING, GL ;
GAUBATZ, JW ;
NAVA, ML ;
BURDICK, BJ ;
BOCAN, TMA ;
GUYTON, JR ;
WEILBAECHER, D ;
DEBAKEY, ME ;
LAWRIE, GM ;
MORRISETT, JD .
ARTERIOSCLEROSIS, 1989, 9 (05) :593-603
[8]  
DAHLEN G, 1978, CLIN GENET, V14, P36
[9]   FIBRINOLYTIC PARAMETERS AND LIPOPROTEIN(A) LEVELS IN PLASMA OF PATIENTS WITH CORONARY-ARTERY DISEASE [J].
FRADE, LJG ;
ALVAREZ, JJ ;
RAYO, I ;
TORRADO, MC ;
LASUNCION, MA ;
AVELLO, AG ;
HERNANDEZ, A ;
MARIN, E .
THROMBOSIS RESEARCH, 1991, 63 (04) :407-418
[10]   RELATIONSHIPS BETWEEN LIPOPROTEIN(A), LIPIDS, APOLIPOPROTEINS, BASAL AND STIMULATED FIBRINOLYTIC REGULATORS, AND D-DIMER [J].
GLUECK, CJ ;
GLUECK, HI ;
TRACY, T ;
SPEIRS, J ;
MCCRAY, C ;
STROOP, D .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1993, 42 (02) :236-246